Transimmunization

Transimmunization is an immunotherapy devised by a Yale University School of Medicine research team, led by Richard Edelson, MD. His co-inventors are Carole Berger, PhD, and Douglas Hanlon, PhD. Transimmunization was developed as a treatment for immunogenic of cancers and T cell mediated immunologic disorders. It involves the efficient transfer of disease-associated antigens to dendritic antigen presenting cells which initiate immunization against these antigens. Learn more...

Clinical Trials

A clinical trial of Transimmunization for the treatment of solid cell tumors in stage IIIB or greater non-small cell lung cancer (NSCLC) is currently underway at Yale. Learn more...